ProCE Banner Activity

Insight on Key Data From the 2023 ESGO Annual Congress Informing Treatment for Endometrial, Cervical, and Ovarian Cancers

Conference Coverage
Clinical Thought

In this commentary, Alexandra Leary, MD, PhD, and Domenica Lorusso, MD, PhD, share their thoughts on key new data for gynecologic cancers presented at the 2023 ESGO annual congress, including new clinical trial results for endometrial, cervical, and ovarian cancers.

Released: October 27, 2023

Share

Faculty

Alexandra Leary

Alexandra Leary, MD, PhD

Co-Director, Department of Medical Oncology
Medical Oncologist, Gynecology
Team Leader, Gynecologic Translational Research Lab, ISERM U981
Institut Gustave Roussy
Past-President, GINEGEPS, GINECO Group on Early Phase Trials
Villejuif, France

Domenica Lorusso

Domenica Lorusso, MD, PhD

Associate Professor 
Catholic University of Sacred Heart
Haear of Clinical Research Development Unit
Fondazione Policlinico Gemelli IRCCS
Rome, Italy

Provided by

Provided by Clinical Care Options (CCO)

ProCE Banner

Supporters

This educational activity is supported by educational grants from AstraZeneca, GlaxoSmithKline, Merck Sharp & Dohme Corp, Novocure, Genmab and Seagen.

AstraZeneca

Genmab

GlaxoSmithKline

Merck Sharp & Dohme Corp.

Novocure

Seagen

Faculty Disclosure

Primary Author

Alexandra Leary, MD, PhD

Co-Director, Department of Medical Oncology
Medical Oncologist, Gynecology
Team Leader, Gynecologic Translational Research Lab, ISERM U981
Institut Gustave Roussy
Past-President, GINEGEPS, GINECO Group on Early Phase Trials
Villejuif, France

Alexandra Leary, MD, PhD: consultant/advisor/speaker: Ability Pharma, Apmonia, AstraZeneca, GlaxoSmithKline, Merck Sharp & Dohme, Owkin; researcher: Ability Pharma, Apmonia, AstraZeneca, Genmab, GlaxoSmithKline, Incyte, Merck Sharp & Dohme, Oseimmuno, Owkin, Pfizer.

Domenica Lorusso, MD, PhD

Associate Professor 
Catholic University of Sacred Heart
Haear of Clinical Research Development Unit
Fondazione Policlinico Gemelli IRCCS
Rome, Italy

Domenica Lorusso, MD, PhD: consultant/advisor/speaker: AstraZeneca, Clovis, Genmab, GlaxoSmithKline, Immunogen, Merck Sharp and Dohme.